KUHNKE JOACHIM
No ORCID on file
· 21 papers in corpus
· active 2010-2011
Frequent coauthors
- BLUME THORSTEN 21
- OTTO CHRISTIANE 21
- SCHMEES NORBERT 21
- HELDMANN DIETER 14
- WINTERMANTEL TIM 14
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…